查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954584

全球经直肠超音波市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析及预测（2026-2034年）

Transrectal Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 163 Pages | 商品交期: 请询问到货日

价格

经直肠超音波市场成长驱动因素

2025年全球经直肠超音波市场规模为 2.7111亿美元，预计将从2026年的2.8797亿美元成长至2034年的4.8964亿美元，预测期内（2026-2034年）年复合成长率（CAGR）为 6.90%。北美地区将在2025年以 29.10%的市场占有率引领市场，这主要归功于该地区前列腺癌的高发病率、先进的医疗基础设施以及有利的医保偿付政策。

经直肠超音波检查（TRUS），也称为直肠超音波或摄护腺超音波，是一种微创影像技术，主要用于诊断摄护腺癌、良性摄护腺增生（BPH）和摄护腺炎。此检查需要将探头插入直肠，并利用声波产生前列腺的详细影像。 TRUS 在前列腺癌筛检、活检引导和影像引导治疗中发挥着非常重要的作用。

新冠疫情的影响

2020年，由于泌尿科手术减少和择期手术推迟，新冠疫情对市场造成了重大影响。由于许多医疗系统优先治疗新冠患者，前列腺癌筛检和诊断影像被推迟。然而，从2020年第四季到2021年第一季，择期手术逐渐恢復，市场需求趋于稳定。从2022年起，预计市场将稳定復苏，并持续成长至2034年。

市场概览及关键指标

  • 市场规模（2025年）：2.7111亿美元
  • 市场规模（2026年）：2.8797亿美元
  • 市场规模预测（2034年）：4.8964亿美元
  • 年复合成长率（2026-2034年）：6.90%
  • 北美市场占有率（2025年）：29.10%

市场趋势

先进影像与人工智慧整合系统的应用

领先企业加速推出具有增强成像功能的创新超音波平台。磁振造影-超音波融合活检、高解析度微超音波和即时弹性成像等技术改变前列腺癌的诊断方式。

例如，ExactVu 微超音波平台采用 29MHz 的频率，可实现前列腺组织的精细可视化。2023年 4月，EDAP TMS 的ExactVu 微超音波活检系统在日本获得销售许可。此外，基于人工智慧的影像分析工具的开发也进行中，以提高诊断准确性。2023年发表的研究强调了人工智慧在经直肠超音波（TRUS）影像辅助前列腺癌鑑别诊断、改善活检引导和提升诊断效果方面日益重要的作用。 市场成长因素

摄护腺癌发生率呈上升趋势

摄护腺癌是全球男性最常见的癌症之一。根据世界癌症研究基金会（WCRF International）的资料，摄护腺癌是男性第二大常见癌症，2020年全球报告的新病例超过 140万例。过去20年发病率的上升显着增加了对早期检测和诊断影像技术（例如经直肠超音波检查（TRUS））的需求。

强而有力的偿付政策和政府主导的措施

支持性的偿付框架和宣传活动促进早期诊断。诸如前列腺癌筛检资助计画和宣传活动等措施推动先进诊断技术的应用。专注于超音波检查偿付策略的会议和政策举措进一步巩固了市场格局。

限制因子

儘管技术不断进步，市场仍面临产品召回和监管等挑战。例如，近年来某些超音波系统的召回影响了其普及率。此外，训练有素的技术人员和泌尿科医生短缺，尤其是在已开发国家，可能会限制检查能力。严格的监管要求也增加了製造商的合规成本。

市场区隔分析

依产品划分

市场依产品分为系统与感测器两大类。

  • 在持续的产品发布和监管批准的支持下，系统细分市场预计到2026年将占据主导地位，市场占有率达到 88.30%。 由于感测器在前列腺癌筛检和诊断中的广泛应用，预计感测器细分市场将实现最高的年复合成长率。

依类型

市场分为推车式/手推车式系统和便携式系统。

  • 到2026年，推车式/手推车式系统将占据92.72%的市场占有率，这主要得益于医院和门诊手术中心（ASC）的高普及率。
  • 由于技术进步和对微创即时成像解决方案需求的不断成长，便携式系统预计将以最高的年复合成长率成长。

依应用

市场依应用分为诊断与影像导引治疗。

  • 到2026年，诊断领域将占据86.22%的市场占有率，这主要得益于摄护腺癌发生率的上升。 由于融合活检和聚焦消融手术的日益普及，影像导引治疗领域预计将保持稳定成长。

依最终使用者划分

市场细分为医院和门诊手术中心（ASC）、诊断实验室和其他机构。

  • 到2026年，医院和门诊手术中心细分市场将占据主导地位，市场占有率达 78.03%，因为大多数前列腺相关手术都在医院进行。
  • 由于对偿付支援和专业影像诊断服务的需求增加，诊断实验室细分市场预计将实现显着成长。

区域洞察

北美

北美市场规模到2025年达到 7,889万美元，凭藉其较高的前列腺癌发病率和完善的医疗保健基础设施，北美将继续保持其主要市场地位。提高公众意识和加强筛检推广工作推动进一步成长。

欧洲

在欧洲，预计年复合成长率将显着提高，这得益于政府为促进前列腺癌早期检测而采取的举措以及先进活检解决方案的监管审批。

亚太地区

由于医疗基础设施的不断完善、老旧超音波系统的升级以及中国、印度和日本等国家医疗支出的增加，亚太地区预计将实现强劲成长。

拉丁美洲、中东和非洲

由于认知度较低和医疗支出不足，这些地区的年复合成长率预计相对较低，但诊断的可及性预计将逐步提高。

主要公司

市场上主要的公司包括：

  • GE Healthcare (BK Medical Holding Company, Inc.)
  • KOELIS
  • Exact Imaging
  • FUJIFILM Corporation
  • Koninklijke Philips N.V.
  • Telemed Medical Systems
  • Strata Imaging
  • HALO Medical Technologies

这些公司致力于收购、产品创新和获得监管部门批准，以增强其竞争力。

产业主要动态

  • 2023年7月：Teleflex 收购 Pallet Life Sciences，以扩展其介入泌尿外科领域的产品线。
  • 2021年12月：GE医疗收购 BK Medical Holding Company, Inc.。
  • 2021年4月：KOELIS 启动了 VIOLETTE 临床试验，用于研究 3D 融合影像导引的局部消融技术。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要发现

  • 主要国家和地区前列腺癌和良性前列腺增生（BPH）的盛行率（2025年）
  • 经直肠超音波市场的技术进步
  • 市场主要企业的差异化策略
  • 主要产业趋势（併购、合作）
  • 影响COVID-19 对市场的影响

第5章 全球经直肠超音波市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 系统
    • 换能器
  • 市场分析、洞察与预测：依类型
    • 推车/手推车底座
    • 便携式
  • 市场分析、洞察与预测：依应用
    • 诊断
      • 摄护腺癌
      • 良性摄护腺增生（BPH）
      • 其他
    • 影像导引治疗
  • 市场分析、洞察与预测：依最终用户
    • 医院及门诊手术中心
    • 诊断实验室
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美经直肠超音波市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲经直肠超音波市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 其他欧洲国家

第8章 亚太经直肠超音波市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳洲
    • 中国
    • 印度
    • 东南亚
    • 其他亚太地区

第9章 拉丁美洲经直肠超音波市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家美国

第10章 中东与非洲经直肠超音波市场分析：洞察与预测（2021年～2034年）

  • 依国家划分
    • GCC
    • 南非
    • 中东和非洲

第11章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • KOELIS
    • GE Healthcare（BK Medical Holding Company, Inc.）
    • Exact Imaging
    • Telemed Medical Systems
    • FUJIFILM Corporation
    • Strata Imaging
    • HALO Medical Technologies
    • GEOTEK
    • Koninklijke Philips N.V.
Product Code: FBI100137

Growth Factors of transrectal ultrasound Market

The global transrectal ultrasound market size was valued at USD 271.11 million in 2025 and is projected to grow from USD 287.97 million in 2026 to USD 489.64 million by 2034, registering a CAGR of 6.90% during the forecast period (2026-2034). North America dominated the market with a 29.10% share in 2025, driven by a high prevalence of prostate cancer, advanced healthcare infrastructure, and favorable reimbursement policies.

Transrectal ultrasound (TRUS), also known as endorectal ultrasound or prostate sonogram, is a minimally invasive imaging technique used primarily for diagnosing prostate-related conditions such as prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis. The procedure involves inserting a probe into the rectum to produce detailed images of the prostate using sound waves. TRUS plays a crucial role in prostate cancer screening, biopsy guidance, and image-guided therapies.

COVID-19 IMPACT

The COVID-19 pandemic significantly affected the market in 2020 due to a decline in urological procedures and postponement of elective surgeries. Several healthcare systems prioritized COVID-19 patients, leading to delays in prostate cancer screenings and diagnostic imaging. However, between Q4 2020 and Q1 2021, elective procedures gradually resumed, stabilizing market demand. From 2022 onwards, the market witnessed steady recovery, and growth is expected to continue through 2034.

MARKET OVERVIEW & KEY METRICS

  • 2025 Market Size: USD 271.11 million
  • 2026 Market Size: USD 287.97 million
  • 2034 Forecast Market Size: USD 489.64 million
  • CAGR (2026-2034): 6.90%
  • North America Market Share (2025): 29.10%

MARKET TRENDS

Launch of Advanced Imaging and AI-Integrated Systems

Leading companies are increasingly launching innovative ultrasound platforms with enhanced imaging capabilities. Technologies such as MRI-US fusion biopsy, high-resolution micro-ultrasound, and real-time elastography are transforming prostate cancer diagnostics.

For example, the ExactVu micro-ultrasound platform uses a 29 MHz frequency to provide detailed visualization of prostate tissues. In April 2023, EDAP TMS received regulatory approval in Japan to commercialize its ExactVu micro-ultrasound biopsy system. Additionally, AI-based imaging tools are being developed to improve diagnostic precision. Studies published in 2023 highlight the growing role of artificial intelligence in differentiating prostate cancer using TRUS images, improving biopsy guidance and diagnostic outcomes.

MARKET GROWTH FACTORS

Increasing Prevalence of Prostate Cancer

Prostate cancer is one of the most common cancers among men globally. According to the World Cancer Research Fund International, prostate cancer is the second most frequently occurring cancer in men, with over 1.4 million new cases reported worldwide in 2020. Rising incidence rates over the past two decades have significantly increased the demand for early detection and diagnostic imaging technologies such as TRUS.

Strong Reimbursement Policies and Government Initiatives

Supportive reimbursement frameworks and awareness programs are encouraging early diagnosis. Initiatives such as funding programs for prostate cancer research and screening awareness campaigns are promoting the adoption of advanced diagnostic technologies. Conferences and policy initiatives focusing on ultrasound reimbursement strategies have further strengthened the market landscape.

RESTRAINING FACTORS

Despite technological advancements, the market faces challenges including product recalls and regulatory scrutiny. For instance, recalls of certain ultrasound systems in previous years have affected adoption rates. Additionally, a shortage of trained technicians and urologists, particularly in developed countries, may limit procedural capacity. Stringent regulatory requirements also increase compliance costs for manufacturers.

MARKET SEGMENTATION ANALYSIS

By Product

The market is segmented into systems and transducers.

  • The systems segment dominated with an 88.30% market share in 2026, supported by continuous product launches and regulatory approvals.
  • The transducers segment is projected to record the highest CAGR due to their widespread use in prostate cancer screening and diagnosis.

By Type

The market is divided into cart/trolley-based and portable systems.

  • The cart/trolley-based segment held 92.72% share in 2026, owing to high adoption in hospitals and ambulatory surgical centers (ASCs).
  • The portable segment is expected to grow at the highest CAGR due to technological advancements and increasing demand for minimally invasive and point-of-care imaging solutions.

By Application

The market is segmented into diagnostic and image-guided treatment.

  • The diagnostic segment accounted for 86.22% share in 2026, driven by the rising incidence of prostate cancer.
  • The image-guided treatment segment is expected to grow steadily due to increasing adoption of fusion biopsy and focal ablation procedures.

By End-User

The market is categorized into hospitals & ASCs, diagnostic laboratories, and others.

  • The hospitals & ASCs segment led with 78.03% share in 2026, as most prostate procedures are conducted in hospital settings.
  • The diagnostic laboratories segment is anticipated to witness significant growth owing to reimbursement support and growing demand for specialized imaging services.

REGIONAL INSIGHTS

North America

North America generated USD 78.89 million in 2025 and remained the leading region due to high prostate cancer prevalence and strong healthcare infrastructure. Increased awareness and screening initiatives are further driving growth.

Europe

Europe is projected to record a significant CAGR, supported by government initiatives promoting early prostate cancer detection and regulatory approvals for advanced biopsy solutions.

Asia Pacific

Asia Pacific is expected to witness strong growth due to expanding healthcare infrastructure, replacement of outdated ultrasound systems, and increasing healthcare expenditure in countries such as China, India, and Japan.

Latin America & Middle East & Africa

These regions are anticipated to grow at a comparatively lower CAGR due to limited awareness and lower healthcare spending, though gradual improvements in diagnostic access are expected.

KEY INDUSTRY PLAYERS

Major companies operating in the market include:

  • GE Healthcare (BK Medical Holding Company, Inc.)
  • KOELIS
  • Exact Imaging
  • FUJIFILM Corporation
  • Koninklijke Philips N.V.
  • Telemed Medical Systems
  • Strata Imaging
  • HALO Medical Technologies

These players focus on acquisitions, product innovation, and regulatory approvals to strengthen their competitive position.

KEY INDUSTRY DEVELOPMENTS

  • July 2023: Teleflex Incorporated acquired Palette Life Sciences AB to expand its interventional urology portfolio.
  • December 2021: GE Healthcare acquired BK Medical Holding Company, Inc.
  • April 2021: KOELIS initiated the VIOLETTE clinical trial for 3D fusion imaging-guided focal ablation.
  • May 2020: EDAP TMS signed a global distribution agreement with Exact Imaging.

CONCLUSION

The global transrectal ultrasound market is projected to grow from USD 271.11 million in 2025 to USD 489.64 million by 2034, expanding at a CAGR of 6.90%. The market is expected to reach USD 287.97 million in 2026, supported by increasing prostate cancer prevalence, advancements in AI-integrated imaging systems, and favorable reimbursement policies. Although challenges such as regulatory scrutiny and technician shortages persist, continuous technological innovation and growing awareness of early cancer detection are expected to sustain long-term market growth through 2034.

Segmentation By Product

  • Systems
  • Transducers

By Type

  • Cart/ Trolley-based
  • Portable

By Application

  • Diagnostic
    • Prostate Cancer
    • BPH (Benign Prostatic Hyperplasia)
    • Others
  • Image-guided Treatment

By End-user

  • Hospitals & ASCs
  • Diagnostic Laboratories
  • Others

By Region

  • North America (By Product, Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Type, Application, End-user, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Type, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Type, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Type, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Prostate Cancer and Benign Prostatic Hyperplasia (BPH), Key Countries/ Region, 2025
  • 4.2. Technological Advancements in Transrectal Ultrasound Market
  • 4.3. Key Differentiating Strategies of Top Players Operating in the Market
  • 4.4. Key Industry Developments (Merges, Acquisitions and Partnerships)
  • 4.5. Impact of COVID-19 on the Market

5. Global Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Systems
    • 5.1.2. Transducers
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Cart/ Trolley-based
    • 5.2.2. Portable
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Diagnostic
      • 5.3.1.1. Prostate Cancer
      • 5.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 5.3.1.3. Others
    • 5.3.2. Image-guided Treatment
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Diagnostic Laboratories
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Systems
    • 6.1.2. Transducers
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Cart/ Trolley-based
    • 6.2.2. Portable
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Diagnostic
      • 6.3.1.1. Prostate Cancer
      • 6.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 6.3.1.3. Others
    • 6.3.2. Image-guided Treatment
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Diagnostic Laboratories
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Systems
    • 7.1.2. Transducers
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Cart/ Trolley-based
    • 7.2.2. Portable
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Diagnostic
      • 7.3.1.1. Prostate Cancer
      • 7.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 7.3.1.3. Others
    • 7.3.2. Image-guided Treatment
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Diagnostic Laboratories
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Systems
    • 8.1.2. Transducers
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Cart/ Trolley-based
    • 8.2.2. Portable
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Diagnostic
      • 8.3.1.1. Prostate Cancer
      • 8.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 8.3.1.3. Others
    • 8.3.2. Image-guided Treatment
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Diagnostic Laboratories
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. Australia
    • 8.5.3. China
    • 8.5.4. India
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Systems
    • 9.1.2. Transducers
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Cart/ Trolley-based
    • 9.2.2. Portable
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Diagnostic
      • 9.3.1.1. Prostate Cancer
      • 9.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 9.3.1.3. Others
    • 9.3.2. Image-guided Treatment
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Diagnostic Laboratories
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Systems
    • 10.1.2. Transducers
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Cart/ Trolley-based
    • 10.2.2. Portable
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Diagnostic
      • 10.3.1.1. Prostate Cancer
      • 10.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 10.3.1.3. Others
    • 10.3.2. Image-guided Treatment
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. KOELIS
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. GE Healthcare (BK Medical Holding Company, Inc.)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Exact Imaging
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. Telemed Medical Systems
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. FUJIFILM Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. Strata Imaging
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. HALO Medical Technologies
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. GEOTEK
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (based on availability)
    • 11.2.9. Koninklijke Philips N.V.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (based on availability)

List of Tables

  • Table 1: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 2: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 3: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 5: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 6: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 7: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 8: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 9: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 10: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 11: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 13: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 14: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 15: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 17: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 18: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 20: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 21: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 23: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 26: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 29: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 32: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 33: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 35: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Transrectal Ultrasound Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Transrectal Ultrasound Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Transrectal Ultrasound Market Value Share (%), by Type, 2025 & 2034
  • Figure 4: Global Transrectal Ultrasound Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Transrectal Ultrasound Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Transrectal Ultrasound Market Value (USD million), by Region, 2025 & 2034
  • Figure 7: North America Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 8: North America Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 9: North America Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 10: North America Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 11: North America Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 12: North America Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 13: North America Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: North America Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 15: North America Transrectal Ultrasound Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 16: North America Transrectal Ultrasound Market Value Share (%), By Country/Sub-region, 2025
  • Figure 17: Europe Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 18: Europe Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 19: Europe Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 20: Europe Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 21: Europe Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 22: Europe Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 23: Europe Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 24: Europe Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 31: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 38: Latin America Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 40: Latin America Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 41: Latin America Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 42: Latin America Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 44: Latin America Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 50: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 51: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Transrectal Ultrasound Market Share (%), By Company, 2025